Insider filing · QURE
Matthew C Kapusta
CEO, Managing Director
profile →
uniQure N.V.
QURE · Healthcare · 28 filings in 24 months
ticker →
Matthew C Kapusta sold $286K of uniQure (QURE)
Executed Feb 25 2025, disclosed Feb 27 2025, 2 days later.
Value, as filed
$286K
26,727 sh × $10.70
Executed
Feb 25 2025
the trade date, as filed
Disclosed
Feb 27 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MKMatthew C Kapusta (CEO, Managing Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in uniQure N.V. (QURE). The largest single filing was $9.4M of QURE (226,316 sh across 5 lots, as filed), executed Sep 24 2025.
The name
QUREHealthcare · uniQure N.V
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Matthew C Kapusta in QURE
QURESALE
uniQure N.V.
$952K21,082 sh across 3 lots
Exec Jul 2
Filed Jul 7 · 4:47 PM ET QURESALE uniQure N.V. $1.8M
35,412 sh across 2 lots
Exec Jun 24
Filed Jun 26 · 5:30 PM ET QURESALE uniQure N.V. $9.4M
206,100 sh across 8 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET QURESALE uniQure N.V. $132K
14,581 sh × $9.06
Exec Mar 4
Filed Mar 6 · 5:30 PM ET QURESALE uniQure N.V. $343K
34,437 sh × $9.95
Exec Mar 2
Filed Mar 4 · 5:30 PM ET QURESALE uniQure N.V. $295K
12,378 sh × $23.86
Exec Feb 25
Filed Feb 27 · 5:30 PM ET QURESALE uniQure N.V. $9.4M
226,316 sh across 5 lots
Exec Sep 24 2025
Filed Sep 26 2025 · 5:30 PM ET QURESALE uniQure N.V. $292K
28,341 sh × $10.29
Exec Mar 4 2025
Filed Mar 5 2025 · 5:30 PM ET